May 11, 2021
Celebrating nearly 15 centuries of service
The University of North Carolina at Chapel Hill is recognizing 118 UNC Lineberger staff and faculty members who will be celebrating a service milestone this year.
Tag: Charles Perou
November 20, 2020
UNC Lineberger faculty among the most highly cited scientists worldwide
Clarivate’s 2020 Highly Cited Researchers list recognized 15 UNC Lineberger members for publishing some of the most influential scientific papers the past decade.
June 24, 2020
AACR honors The Cancer Genome Atlas researchers with 2020 Team Science Awards
UNC Lineberger faculty have held leadership and team membership roles with The Cancer Genome Atlas, which was launched in 2006.
September 16, 2019
Susan G. Komen awards nearly $1.5M in breast cancer research grants to UNC Lineberger
Susan G. Komen® today announced it was providing $1.45 million in research grants to three UNC Lineberger Comprehensive Cancer Center members as part of a national campaign focused on metastatic breast cancer, developing new, more-effective treatments, and addressing disparities in breast cancer outcomes. The grants support Komen’s commitment to achieve its Bold Goal to reduce …
April 19, 2019
Study provides insights behind hyperactivation of key cell proliferation signal
The idea was simple: find the faulty signals that drive cancerous growth in cells, and block them. But what University of North Carolina Lineberger Comprehensive Cancer Center researcher Pengda Liu, PhD, has discovered, when it comes to cancer, even straightforward concepts can become complicated. “When you find a target and inhibit it, you find the …
November 19, 2018
Scientists train a computer to classify breast cancer tumors
Using technology similar to the type that powers facial recognition on a smartphone, Charles M. Perou, PhD, Melissa Troester, PhD, and Heather D. Couture have trained a computer to analyze breast cancer images and then classify the tumors with high accuracy.
July 19, 2018
Discovery of kidney cancer driver could lead to new treatment strategy
In a study published in the journal Science, researchers led by UNC Lineberger's Qing Zhang, PhD, suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.